Health care stocks were higher Friday afternoon, with the NYSE Health Care Index adding 0.1% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, AbbVie (ABBV) reported better-than-expected Q4 results amid robust sales of Skyrizi and Rinvoq, prompting the drugmaker to lift its long-term combined revenue outlook for the two immunology drugs. Its shares popped 5.4%.
Walgreens Boots Alliance (WBA) shares fell 7.8%. The company said Thursday its board has suspended quarterly dividend payments while management refines its capital allocation policy to be consistent with a long-term turnaround strategy.
AstraZeneca (AZN) has cancelled a plan to invest 450 million pounds ($558.3 million) in a UK vaccine plant in Liverpool. Its shares were down 0.4%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。